Clinical Trials in San Francisco

Showing 8461-8480 of 12,991 trials

DDI Effectiveness and Clinical Awareness

NCT03581994

The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and whether those physicians, when given access to Aegis Drug-Drug Interaction test results, improve patient management, take steps to reduce DDI risk, and optimize unnecessary resource utilization.

Drug-Drug Interactions

Qure Healthcare, LLC330 participantsStarted May 2018

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

NCT02337062

A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).

PONV

Acacia Pharma Ltd1,147 participantsStarted Feb 2015

Sheffield, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +22 more locations

DDI Effectiveness and Clinical Awareness

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Find Trials by Condition in San Francisco

DF4 Connector System Post-Approval Study

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Safety Study of ExAblate for the Treatment of Uterine Fibroids

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Whole-Body Cooling for Birth Asphyxia in Term Infants

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

UltraShape Power for Abdominal Fat and Circumference Reduction

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

52-104 Week Off-therapy Second Extension to Study CSPP100A2365